Looking forward to update soon, especially in India. There is no doubt the company has been incredibly slow at R&D and getting new products to market.
I have been invested for 16 years and there is still no completed trial for burns, ulcer, breast or hernia application. Some of these indications should have had by now published research supporting each indication for what we all know is a wonderful product. Even the ulcer trial issues are so frustrating. Can you imagine if we had approval with reimbursement in burns, ulcers as well as wounds. Hopefully over the next 1-2 years. Fingers crossed.
Have a nice day
BILL
Medtronic has entered the market for resorbable mesh Ventral Hernia Repair, page-12
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
0.110(4.53%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.46 | $2.57 | $2.46 | $3.283M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5750 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 3040 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |